Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
WO2009080182 A1 2009-07-02 [WO200980182] / 2009-07-02
申请号/申请日
2008WO-EP10265 / 2008-12-04
发明人
MUELLER KLAUS-HELMUT;GESING R F ERNST;WALDRAFF CHRISTIAN;KEHNE HEINZ;FEUCHT DIETER;HILLS MARTIN;ROSINGER CHRIS;DITTGEN JAN;
申请人
BAYER CROPSCIENCE;
主分类号
IPC分类号
A01N-043/80A01N-043/90A01P-013/00C07D-413/04C07D-413/14C07D-498/04
摘要
(WO200980182) What are described are compounds of the general formula (I) in which the particular substituents are each defined as specified in the description.  The compounds of the general formula (I) can be used as herbicides and crop growth regulators.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2007EP-0024727 2007-12-20 2008DE-10006005 2008-01-25
主权利要求
(WO200980182) Claims 1. N- Azinyl-N ' - pyridyl sulfonyl-ureas of the general formula (I), in which V, W, X and Y are chosen such, that one of these indices represents nitrogen and the remaining indices represent carbon atoms for, which is unsubstituted or with the group represented R8may be substituted; A is selected from the group, consisting of nitrogen and CR9; wherein R9is selected from the group, consisting of hydrogen, alkyl, halo and Haloalkyl; R1is selected from the group, consisting of hydrogen and an optionally substituted radical from the group consisting of alkyl, alkoxy, Alkoxyalkyl, alkenyl, alkynyl, Cycloalkyl, cycloalkylalkyl, Aralkyl and aryl; R2is selected from the group, consisting of hydrogen, halogen, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkylthio, optionally halogen-substituted Alkylamino or optionally halogen-substituted Dialkylamino: R3is selected from the group, consisting of hydrogen, halogen, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkylthio, optionally halogen-substituted Alkylamino or optionally halogen-substituted Dialkylamino; R4to R7, each independently, are selected from the group, consisting of hydrogen, halogen, Cyano, alkyl, alkoxy, Alkylthio, Alkylsulfinyl, Alkylsulfonyl, Alkylamino, Dialkylamino, Alkylcarbonyl, Alkoxycarbonyl, Alkylaminocarbonyl or dialkylaminocarbonyl, where the radicals can be unsubstituted or one or more radicals selected from the group, consisting of halogen, Cyano, alkoxy or Alkylthio, may carry, or R4and R6or R5and R7by oxygen or sulfur interrupted alkylidene group optionally present; R8is selected from the group, consisting of hydrogen, halogen, Cyano, Thiocyanato, Nitro, alkyl, alkoxy, Alkylthio, Alkylsulfinyl, Alkylsulfonyl, Alkylamino, Dialkylamino, Alkylcarbonyl, Alkoxycarbonyl, alkylaminocarbonyl, or dialkylaminocarbonyl, where the radicals can be unsubstituted or one or more radicals selected from the group, consisting of halogen, Cyano, alkoxy and Alkylthio, may carry; Q is selected from the group, consisting of oxygen, sulfur or and salts of compounds of the formula (I). 2. N- Azinyl-N ' - pyridyl sulfonyl-ureas according to claim 1, characterized in, that the Substituent A is selected from the group, consisting of nitrogen and CH. 3. N- Azinyl-N ' - pyridysulfonyl-ureas according to claim 1 or 2, characterized in, that the Substituent R1is selected from the group, consisting of hydrogen, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkoxyalkyl, optionally halogen-substituted alkenyl and optionally halogen-substituted alkynyl. 4. N- Azinyl-N ' - sulfonyl-ureas pyridyl according to any one of claims 1 to 3, characterized in, that the Substituent R2is selected from the group, consisting of hydrogen, halogen, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkylthio, optionally halogen-substituted Alkylamino and optionally halogen-substituted Dialkylamino. 5. N- Azinyl-N ' - pyridysulfonyl-ureas according to any one of claims 1 to 4, characterized in, that the Substituent R3is selected from the group, consisting of hydrogen, halogen, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkylthio, optionally halogen-substituted Alkylamino and optionally halogen-substituted Dialkylamino. 6. N- Azinyl-N ' - pyridysulfonyl-ureas according to any one of claims 1 to 5, characterized in, that the substituents R4to R7, each independently, are selected from the group, consisting of hydrogen, Halogen, Cyano, Thiocyanato, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkylthio, optionally halogen-substituted Alkylsulfinyl, optionally halogen-substituted Alkylsulfonyl, optionally halogen-substituted Alkylamino, optionally halogen-substituted Alkylcarbonyl, optionally halogen-substituted Alkoxycarbonyl or optionally substituted by Halogen-substituted Alkylaminocarbonyl. 7. N- Azinyl-N ' - pyridysulfonyl-ureas according to any one of claims 1 to 6, characterized in, that the Substituent R8is selected from the group, consisting of hydrogen, halogen, Cyano, Thiocyanato, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy, optionally halogen-substituted Alkylthio, optionally halogen-substituted Alkylsulfinyl, optionally halogen-substituted Alkylsulfonyl, optionally halogen-substituted Alkylamino, optionally halogen-substituted Alkylcarbonyl, optionally halogen-substituted Alkoxycarbonyl and optionally halogen-substituted Alkylaminocarbonyl. 8. The method for producing N- Azinyl-N ' - pyridyl sulfonyl-ureas according to any one of claims 1 to 7, characterized by one of the following Method Steps: (a) reacting (4.5- Dihydroisoxazol-3-yl) pyridine-n-thioxocarbonyl sulfonamides of the general formula (II) with a heterocyclic (Thio) - carbamate of the general formula (III) wherein R12a substituted or unsubstituted (d-C2O) - aryl or alkyl group such as - sersactive Kohlenwassubstance, preferably optionally substituted phenyl or optionally substituted (C-i-C-O-alkyl and wherein V, W, X, Y, R1to R8, Q and A have the meaning according to any one of claims 1 to 7 have; or (b) reaction of (4.5- Dihydroisoxazol-3-yl) pyridine-sulfonsäureiso (thio) cyanates of the general formula - (IV)  with an amino heterocycle of the general formula (V) wherein V, W, X, Y, R1to R8, Q and A have the meaning according to any one of claims 1 to 7 have; or (c) reaction of (4.5- Dihydroisoxazol-3-yl) pyridine-sulphonyl (thio) carbamates of the general formula (VI)  wherein R12is a substituted or unsubstituted (C1 - C20) - hydrocarbon radical such as aryl or alkyl, preferably optionally substituted phenyl or optionally substituted (d-C4) - alkyl, with an amino heterocycle of the general formula (V)  wherein V, W, X, Y, R1to R8, Q and A have the meaning according to any one of claims 1 to 7 have; or (d) reaction of (4.5- Dihydroisoxazol-3-yl) pyridine-sulphonamides of the general formula (II)  with an lso (thio) cyanate of the general formula (VII)  optionally in the presence of a reaction auxiliary, where R1is hydrogen and V, W, X, Y, R2to R8, Q and A have the meaning according to any one of claims 1 to 7 have; or (e) reacting an amino heterocycle of the general formula (V)  initially reacted with a carbonic ester and the presence of a base catalyst of the general formula formed intermediate (III)  in a one-pot reaction with a (4.5- Dihydroisoxazol-3-yl) pyridin - sulfonamide of the general formula (II)  wherein V, W, X, Y, R1to R8, Q and A have the meaning according to any one of claims 1 to 7 have; or (f) reaction of (4.5- Dihydroisxazol-3-yl) pyridine-sulphonic acid halides of the general formula (VIII)  wherein hal is a halogen atom with a (Thio) cyanate to an lso - (Thio) cyanate of the general formula (IV)  or a solvated (stabilized) derivative, and subsequently with an amino heterocycle of the general formula (V)  wherein V, W, X, Y, R1to R8, Q and A have the meaning according to any one of claims 1 to 7 have; or (g) reaction of (4.5- Dihydroisoxazol-3-yl) pyridine-sulphonic acid amides of the general formula (II) a Bis-carbamate of the general formula heterocyclic (IX),  wherein R12is a substituted or unsubstituted (C1C2 -0) - hydrocarbon radical, in the presence of a basic reaction auxiliary, where Q is oxygen and V, W, X, Y, R1to R8, and A the meaning according to any one of claims 1 to 7 have; or (h) reaction of (4.5- Dihydroisoxazol-3-yl) pyridine-sulphonic acid amides of the general formula (II)  base catalyzed reaction of the resulting intermediate with a carbonic ester and of the general formula (VI)  in a one-pot reaction with an amino heterocycle of the general formula (V)  wherein V, W, X, Y, R1to R8, Q and A as defined in any one of Have claims 1 to 7. 9. Compounds of the general formula (II)  in which the radicals V, W, X, Y, R4, R5, R6, R7and R8the meanings according to any one of claims 1 to 7 have. 10. Compounds of the general formula (VIII)  in which the radicals V, W, X, Y, R4, R5, R6, R7, R8and hal have the meanings according to any one of claims 1 to 7 have. 11. Compounds of the general formula (Xl) in which the radicals V, W, X, Y, R4, R5, R6, R7, R8and hal have the meanings according to any one of claims 1 to 7 have. 12. Compounds of the general formula (X)  in which the radicals V, W, X, Y, R4, R5, R6, R7and R8the meanings according to any one of claims 1 to 7 have. 13. Compositions, comprising at least one compound of the general formula (I) according to any one of claims 1 to 7. 14. Composition according to claim 13, characterized in, that the composition comprises at least one further active ingredient, which is selected from the group, consisting of at least one further herbicide and at least one Safener. 15. Use of the compounds of general formula (I) according to any one of claims 1 to 7 for use as herbicides and plant growth regulators. 16. Use of the compositions according to claim 14 or 15 for use as herbicides and plant growth regulators. 17. Use according to claim 15 or 16 for controlling plants in specific plant crops or crop protection regulator.
法律状态
(WO200980182) LEGAL DETAILS FOR WO2009080182  Actual or expected expiration date=2011-06-20    Legal state=DEAD    Status=LAPSED     Event publication date=2008-12-04  Event code=WO/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=WO WOEP2008010265  Application date=2008-12-04  Standardized application number=2008WO-EP10265     Event publication date=2009-07-02  Event code=WO/A1  Event type=Examination events  Published application with search report  Publication country=WO  Publication number=WO2009080182  Publication stage Code=A1  Publication date=2009-07-02  Standardized publication number=WO200980182     Event publication date=2011-06-20  Event code=WO/EETL  Event type=Event indicating Not In Force  PCT Application validity period expired. LEGAL DETAILS FOR DESIGNATED STATE BRPI0820842  Actual or expected expiration date=2015-06-09    Legal state=DEAD    Status=REVOKED   Corresponding cc:  Designated or member state=BR Corresponding appl: BRPI0820842  Application date in the designated or member state=2008-12-04   Application number in the designated or member state=2008BR-0020842 Corresponding cc:  Designated or member state=BR Corresponding pat: BRPI0820842  Publication stage code in the designated or member state=A2  Publication date in the designated or member state=2014-12-23   Publication number in the designated or member state=BR200820842    Event publication date=2014-12-23  Event code=WO/ENP  Event type=Entry into national phase  Entry into the national phase in: Corresponding cc:  Designated or member state=BR   Effective date of the event=2010-06-17     Event publication date=2015-09-08  Event code=BR/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=BR  LEGAL DETAILS FOR DESIGNATED STATE CA2710113  Actual or expected expiration date=2012-12-04    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=CA Corresponding appl: CA2710113  Application date in the designated or member state=2008-12-04   Application number in the designated or member state=2008CA-2710113 Corresponding cc:  Designated or member state=CA Corresponding pat: CA2710113  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2009-07-02   Publication number in the designated or member state=CA2710113    Event publication date=2010-06-18  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=CA     Event publication date=2013-01-29  Event code=CA/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=CA  LEGAL DETAILS FOR DESIGNATED STATE CN101903379  Actual or expected expiration date=2013-03-20    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=CN Corresponding appl: CN200880122249  Application date in the designated or member state=2008-12-04   Application number in the designated or member state=2008CN-80122249 Corresponding cc:  Designated or member state=CN Corresponding pat: CN101903379  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2010-12-01   Publication number in the designated or member state=CN101903379    Event publication date=2013-03-20  Event code=CN/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=CN  LEGAL DETAILS FOR DESIGNATED STATE EP2225234  Actual or expected expiration date=2011-12-07    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=EP Corresponding appl: EP08864548  Application date in the designated or member state=2008-12-04   Application number in the designated or member state=2008EP-0864548 Corresponding cc:  Designated or member state=EP Corresponding pat: EP2225234  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2010-09-08   Publication number in the designated or member state=EP2225234    Event publication date=2009-08-26  Event code=WO/121  Event type=Designated states  EP: The EPO has been informed by wipo that ep was designated in this application Corresponding cc:  Designated or member state=EP     Event publication date=2012-05-30  Event code=EP/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=EP  LEGAL DETAILS FOR DESIGNATED STATE US2011028318  Actual or expected expiration date=2012-07-22    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=US Corresponding appl: US12809416  Application date in the designated or member state=2008-12-04   Application number in the designated or member state=2008US-12809416 Corresponding cc:  Designated or member state=US Corresponding pat: US2011028318  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2011-02-03   Publication number in the designated or member state=US20110028318    Event publication date=2010-06-18  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=US     Event publication date=2012-07-22  Event code=US/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=US  LEGAL DETAILS FOR DESIGNATED STATE ZA201003388  Actual or expected expiration date=2028-12-04    Legal state=ALIVE    Status=GRANTED   Corresponding cc:  Designated or member state=ZA Corresponding appl: ZA201003388  Application date in the designated or member state=2010-05-13   Application number in the designated or member state=2010ZA-0003388 Corresponding cc:  Designated or member state=ZA Corresponding pat: ZA201003388  Publication stage code in the designated or member state=B  Publication date in the designated or member state=2011-03-30   Publication number in the designated or member state=ZA201003388    Event publication date=2011-03-30  Event code=ZA/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=ZA
专利类型码
A1
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部